![](/img/cover-not-exists.png)
Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders
Ackerstein, A, Kedar, E, Slavin, SVolume:
78
Journal:
Blood
DOI:
10.1182/blood.v78.5.1212.1212
Date:
September, 1991
File:
PDF, 454 KB
1991